By Jennifer Ahlstrom | Posted - Dec 13th, 2018





Day 4 of Myeloma Giving: Give Gratitude for Multiple Myeloma Progress

Day 4 of Myeloma Giving: Give Gratitude for Multiple Myeloma Progress

From December 10 – 21, the Myeloma Crowd is sharing 12 Days of Myeloma Giving. Please share this post and invite your friends and family to participate. Each day we will share something you can give to lift others. These gifts will save lives, lengthen lives and makes lives happier and more meaningful – maybe even your own.

My friend who has ALS (and a wicked sense of humor) told me, "I'm jealous of your terminal disease." With a terminal disease, the humor can be dark, but he is right. If you have to get a terminal disease, multiple myeloma is better than ALS which has no biomarkers and no available treatments. 

There was no better place to see this in full force than the recent ASH conference. It was a flood of information as usual, but what stood out to me the most was the sheer number of myeloma doctors performing such incredible research and stunning number of companies in the space trying to develop curative drugs - just for myeloma. It's completely jaw-dropping to me what is happening. 

Here are just a few advances and we haven't even posted a third of the information coming out of ASH yet! 

So today, please thank a myeloma doctor, a myeloma researcher, a foundation or group providing funding, a pharma company, or your care team by sharing this article with the Twitter tag #mmsm or on FaceBook. You can also send a quick email or better yet, an old-fashioned handwritten card. 

Even with a cancer none of us ever wanted, we are so fortunate to be getting incredible attention to drive towards a cure faster. 

Jennifer Ahlstrom
About the Author

Jennifer Ahlstrom - Jenny A - Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.


Add a Comment



Thanks to our Myeloma Crowd Community sponsors:

.                         .       .